Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
Clinical trial NCT05202509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05202509
- Sponsor
- NewAmsterdam Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2026-11-01
- Enrollment
- 9541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.